A novel BH3-like domain in BID is required for intramolecular interaction and autoinhibition of pro-apoptotic activity

被引:48
作者
Tan, KO [1 ]
Tan, KML [1 ]
Yu, VC [1 ]
机构
[1] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore
关键词
D O I
10.1074/jbc.274.34.23687
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon activation of the Fas apoptotic signaling pathway, Bid, a "BH3 domain-only" pro-apoptotic molecule, is cleaved by caspase-8 into a 6.5-kDa N-terminal and a 15-kDa BH3 domain-containing C-terminal fragment, referred to as t(n)-Bid and t(c)-Bid, respectively. t(c)-Bid is a more potent inducer of apoptosis than full-length Bid, suggesting that the N-terminal region of Bid has an inhibitory effect on its pro-apoptotic activity. Here, we report the identification of a novel BH3-like motif (amino acid residues 35-43) in t(n)-Bid. Although Bid does not homodimerize, t(n)-Bid is able to associate avidly with t(n)-Bid. Site directed mutagenesis revealed that both the novel BH3-like and BH3 domains are necessary for direct binding between t(n)-Bid and t(c)-Bid. While full-length Bid does not associate with t(n)-Bid, substitution of Leu(35) a critical residue in mediating t(n)-Bid/t(c)-Bid interaction, with Ala in full-length Bid is sufficient to establish Bid/t(n)-Bid interaction. Interestingly, the L35A Bid mutant is as effective as t(c)-Bid in inducing apoptosis and binding Bcl-X-L. We propose that the intramolecular interaction involving the BH3-like and BH3 domains serves to regulate the pro-apoptotic potential of Bid.
引用
收藏
页码:23687 / 23690
页数:4
相关论文
共 29 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]  
Bai C, 1997, METHOD ENZYMOL, V283, P141
[3]  
BOYD JM, 1995, ONCOGENE, V11, P1921
[4]   A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS [J].
CHITTENDEN, T ;
FLEMINGTON, C ;
HOUGHTON, AB ;
EBB, RG ;
GALLO, GJ ;
ELANGOVAN, B ;
CHINNADURAI, G ;
LUTZ, RJ .
EMBO JOURNAL, 1995, 14 (22) :5589-5596
[5]   Solution structure of BID, an intracellular amplifier of apoptotic signaling [J].
Chou, JJ ;
Li, HL ;
Salvesen, GS ;
Yuan, JY ;
Wagner, G .
CELL, 1999, 96 (05) :615-624
[6]   The C-elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9 [J].
Conradt, B ;
Horvitz, HR .
CELL, 1998, 93 (04) :519-529
[7]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[8]   Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death [J].
Gross, A ;
Yin, XM ;
Wang, K ;
Wei, MC ;
Jockel, J ;
Millman, C ;
Erdjument-Bromage, H ;
Tempst, P ;
Korsmeyer, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1156-1163
[9]   Blk, a BHS-containing mouse protein that interacts with Bcl-2 and Bcl-xL, is a potent death agonist [J].
Hegde, R ;
Srinivasula, SM ;
Ahmad, M ;
Fernandes-Alnemri, T ;
Alnemri, ES .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :7783-7786
[10]   A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis [J].
Hunter, JJ ;
Parslow, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8521-8524